“driving with dementia”的搜索结果，显示 301-310 项，共有 520 项

1. 神经科- 临床试验- 妙佑医疗国际

   ALSENLITE: Senolytics for Alzheimer's Disease. Rochester, Minn. The purpose of this study is to measure target engagement in cerebrospinal fluid (CSF) and blood ...

2. 神经科- 临床试验- 妙佑医疗国际

   The goal of this study is to gain a better understanding of the status of advanced care planning among caregivers of patients with dementia and examine how this ...

3. 神经科- 临床试验- 妙佑医疗国际

   The goal of this study is to gain a better understanding of the status of advanced care planning among caregivers of patients with dementia and examine how this ...

4. 神经科- 临床试验- 妙佑医疗国际

   There is evidence that neurodegenerative changes precede clinical symptoms in Alzheimer's disease by two decades (Villemagne et al, 2013). Early detection is ...

5. 神经科- 临床试验- 妙佑医疗国际

   ALSENLITE: Senolytics for Alzheimer's Disease. Rochester, Minn. The purpose of this study is to measure target engagement in cerebrospinal fluid (CSF) and blood ...

6. 早发型阿尔茨海默病：65 岁之前开始出现症状

   LEADS. Alzheimer's Association. http://alz.org/leads/overview.asp. Accessed March 28, 2022. 2023 Alzheimer's disease facts and figures. Alzheimer's & Dementia ...

7. 神经科- 临床试验- 妙佑医疗国际

   ... Alzheimer's Disease (AD) to inform and select the best blood, CSF ... Magnetic Resonance Elastography of Dementia. Rochester, Minn. The purpose of ...

8. 神经科- 临床试验- 妙佑医疗国际

   ALSENLITE: Senolytics for Alzheimer's Disease. Rochester, Minn. The purpose of this study is to measure target engagement in cerebrospinal fluid (CSF) and blood ...

9. 神经科- 临床试验- 妙佑医疗国际

   The goal of this study is to gain a better understanding of the status of advanced care planning among caregivers of patients with dementia and examine how this ...

10. 神经科- 临床试验- 妙佑医疗国际

    Rochester, Minn. The purpose of this study is to investigate whether recent, groundbreaking discoveries about key pathophysiologic processes that drive ...